Jake and others,
I wouldn't worry too much about Mangrove selling. Their business plan is more geared to trading oppotunities. They were owners of our convertible debt, and undoubtedly made a lot of money shorting over the years. Companies like Mangrove won't hold common shares on the same terms as others for the long haul.
Hello to all by the way. My "ignore" feature wasn't working, and I saw the typically semi-literate insults from Jeff. I hope his views are his alone, but the internet brings out the beast in people lacking success in their real lives. I'll see if I can get the ignore button to work again.
As for ANIP trading, candor is important. I wish more posters observed this. My calls are in the toilet come October 15. However, at this price, ANIP is fairly valued, so I've picked up some shares, but not as many as I had. I expect improvements with Lalwani, but not before he does what new CEOs usually do: scrub the company for anything overvalued and get rid of it. The next quarterly call may reveal that, but people usually breathe a sigh of relief.
About Lalwani, he better be good. I will say that I was shocked at the amount of his "inducement grant." Options for 179,643 shares @$29, vesting over 4 years in 25% increments and expiration after 10 years. What was especially shocking (to me) is that shareholders had just authorized 1.1M shares for employee grants, and that this 179,643 was outside that allotment. Those ANIP directors love to give away our stock. I hope this gets earned.
Be well everyone. The stable had a 2nd at Churchill Downs a week ago, and a win at Belmont on Friday. Still no one allowed in the stands, but let's hope that we turn the corner on Covid-19 soon.
Market Data 
Markets 
